To date, reliable and sensitive methods to localize the estrogen receptor (ER) in rat tissues and human breast cancers have required the use of frozen sections. This not only incurs poor tissue smwmrc but also precludes the study of small breast lesions that are usually paraffin embedded for histological evaluation. We have developed and optimized a dinitrophenyl hapten sandwich staining (DHSS) immunocytochemical procedure to demonstrate ER in paraff'm-embedded, hormone-sensitive tissues of the rat and in human breast cancers. The method was applicable to formalin-and Bouins-fixed material, with trypsinization ofsections being essential. The immunocytochemical system utilized a dimtrophenyi (DNP) hapten-labeied monodonal antibody to the receptor. Mouse 1gM anti-DNP was used secondarily, followed by a DNP/peroxidase complex, diaminobenzidine/
Breast cancer specimens (n = 17) were excised from fresh tissue obtamed at mastectomy and immediately placed on ice. A 1-cm3 slice of tissue was cut from each sample and fixed routinely with either 10% formalin buff red to pH 7.4 for 12-18 hr, methacarn (45)for 18-24 hr, or Bouin's fixative for 3 hr at room temperature. Adjacent slices of rumor tissue were frozen and cryostat sections were fixed and assayed using the ER-ICA procedure (Abbott Laboratories; Chicago, IL) (5, 12, 23, 24, 26, 37, 38, 40, 67) to further assess their ER status. After fixation, the above rat and human tissues were rinsed twice in PBS (0.01 M, pH 7. rat tissues with a reduced ER content (uteri from rats medically castrated at 28 days and sacrificed at 50 days); and (c) sections ofsuitably fixed human breast tumors known to be ER negative (as assessed using the ER-ICA procedure). 
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Application of the DHSS Procedure
Rat Estrogen-sensitive Tissues.
Bouin's-fixed and trypsinized paraffin sections ofuteri from 50-day-old rats in estrus showed DNP- Where terminal end buds (TEBs) were present, staining was found in the nuclei of the cortical epithelial cells, which were generally large and regular ( Figures  4b and 4c ). This immunostaining was weak and speckled throughout the ER-positive nuclei ( Figure  4c ).
The signal, however, was heterogeneous between cells, being stronger and clumped within occasional irregular nuclei adjacent to the lumen ( Figure  4c ). Staining was completely absent in few ofthe cortical cells (Figures  4b and 4c ). However, immunostaining was weak or absent within the TEB peripheral cap cells (Figures  4b and 4c ) and in the ductal myoepithelial cells ( Figures  4d and 4e Figure  6a ; see also Figure  1 ). Staining was absent in the epitheiial and stromal cells of ER-negative tumors (n = 4; Figure 6b ). Tumor-associated normal and cystic mammary structures stained intensely in many of their constituent epithelial cells ( Figure  6c ). 7 ). The endometrial glandular cells, however, stained very intensely. As described above, Bouin's-or formalin-fixed ER-negative human breast tumors (n = 4, as assessed by the ER-ICA procedure on adjacent frozen material), remained unstained by the DHSS procedure ( Figure  6b ).
Controls

Discussion
Antigenic determinants, including those in the estrogen receptor, may be scarce in paraffin-embedded tissues as a direct consequence oftheir partial destruction during the fixation and embedding regimen. It is therefore essential that any immunocytochemical procedure for the study of this receptor in paraffin-embedded material be highly sensitive.
The dinitrophenyl hapten sandwich staining system (DHSS) (15, 22, 27, 29, 30, 53) has been shown to meet this requirement and in the present study localized the receptor in (14, 15, 27, 30, 31, 32, 53, 54, 70) . The described procedure necessitated the optimization of both tissue fixation and subsequent mild trypsinization to re-expose fixation-masked epitopes (1, 6, 19, 20, 21, 28, 58, 62 ;; i . 
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:-LEo This is in agreement with work performed previously by many authors using either frozen or paraffin-embedded material (1, 5, 11, 24, 43, 44, 68, 71, 72) .
Prolonged fixation resulted in a progressive loss of antigenicity (11, 12, 43, 44, 46, 48 (8, 24, 25, 49, 52, 59, 60, 61, 63) and immunoperoxidase studies (13, 51, 63, 71, 72; and ER Dc Sombre, personal communication -4,6,1l,19,20,41,42,46,55,56,62) , and indirect, using antibodies to estrogen (2, 7, 39, 42, 50 
